Challenges in existing infrastructure limit the growth of genomic data sharing.

Scaling

Adding institutions to federated systems is cumbersome — legal review, IRB, data-use agreements, security audits, accreditation for each relationship. What if we could de-risk this process?

Scaling. Adding institutions to federated systems is cumbersome — legal review, IRB, data-use agreements, security audits, accreditation for each relationship. What if we could de-risk this process?

Can we accelerate discovery by streamlining genomic data sharing?

Introducing

ZEENOME

An experimental genomic data-sharing protocol powered by ZK.

Composable trust

Accreditation, attestations, and allowlists let new institutions reuse trust already on the network — instead of repeating legal review, IRB, audits, and agreements for every relationship. That de-risks onboarding: one inquiry can reach many accredited organizations.

Composable trust. Accreditation, attestations, and allowlists let new institutions reuse trust already on the network — instead of repeating legal review, IRB, audits, and agreements for every relationship. That de-risks onboarding: one inquiry can reach many accredited organizations.

Genomic collaboration unlocks answers–
ZEENOME protects patients along the way.

Carrier screen

Risk

An insurer sees a disease risk in your DNA—and raises your premium.

Reward

A routine screen finds a condition before it becomes a crisis.

How it Works

Follow the Trust Chain step by step — accreditor, clinician, registry, researcher, and patient — and see the cryptography that secures each link.

Explore the Trust Chain